The presence of the BRAF autoinhibitory domain and additional oncogenic mutation(s) and the presence or absence of negative regulators of BRAF (e.g., Sred), and negative feedback loops are additional potentially modulatory factors of tumor phenotypes (Table 3). Here, BRAF is linked to neoplasm.